BNTC

Benitec Biopharma Inc

$12.54
0.16 (1.26%) Today
Compare BNTC
Market Cap
$436M+11.7%
Revenue (TTM)
$0
Net Income (TTM)
$-38,039,190
EPS (TTM)
-1.11
Shares Out
34.35M
Open
$12.70
Previous Close
$12.70
Day Range
$12.54 – $13.01
52-Week Range
$9.85 – $16.76
Beta
0.29
Earnings Date
Sep 21, 2026
Volume
2.71K
Avg Volume
143.36K
Analyst Rating
Buy
Exchange
NASDAQ NMS - GLOBAL MARKET

About BNTC

Benitec Biopharma Limited is an Australian biotechnology company founded in 1997. It is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases using DNA-directed RNA interference (ddRNAi) technology.

Related

News